Rosacea is a chronic but treatable skin condition that primarily affects the central face and is often characterised by flare-ups and remissions. Although rosacea may develop in many ways and at any age, patient surveys indicate that it typically begins any time after age 30 as flushing or redness on the cheeks, nose, chin or forehead that may come and go. Studies have shown that over time the redness tends to become ruddier and more persistent, and visible blood vessels may appear. Left untreated, inflammatory bumps and pimples often develop, and in severe cases — particularly in men — the nose may grow swollen and bumpy from excess tissue. In as many as 50 per cent of patients, the eyes are also affected, feeling irritated and appearing watery or bloodshot.
In surveys by the National Rosacea Society (NRS), nearly 90% of rosacea patients said this condition had lowered their self-confidence and self-esteem, and 41% reported it had caused them to avoid public contact or cancel social engagements. Among those with severe rosacea, nearly 88 % said the disorder had adversely affected their professional interactions.
A panel of experts will review a rosacea case and present their individual observations and treatment approaches.